论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
复发化疗治疗不确定性树突状细胞瘤:病例报告及文献综述
Authors Li Y, Zhang C, Xiong J
Received 8 July 2023
Accepted for publication 30 September 2023
Published 20 October 2023 Volume 2023:16 Pages 2985—2993
DOI https://doi.org/10.2147/CCID.S429566
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Jeffrey Weinberg
Abstract: Indeterminate dendritic cell tumor (IDCT) is an extremely uncommon histiocytic and dendritic neoplasms subtype that presents as single or multiple papules. There is currently no standard method for diagnosis and treatment, and the selection of therapeutic approaches is mainly based on successful examples of folk medicine. We describe a case of a pathology diagnosed indeterminate dendritic cell tumor, which shows the presence of CD1a, S100, and CD68, but lack langerin. She was treated with multi-chemotherapy regimens used to treat lymphoma and gained good results short term but was easy to recur. In addition, we reviewed the literature on the effectiveness and safety of chemotherapy in IDCT patients.
Keywords: indeterminate cell histiocytosis, indeterminate dendritic cell tumor, chemotherapy, recurrent, S100 atypical